News
Life Sciences Deal Flows Boost Positive Mood at JPMorgan Healthcare Conference Seeking Alpha
View ArticleFierceBiotech's 2011 Fierce 15 Biotech Companies
FierceBiotech's 2011 Fierce 15 Biotech Companies Fierce Biotech
View ArticleEpizyme grabs $4M from partner GlaxoSmithKline
Epizyme grabs $4M from partner GlaxoSmithKline Bizjournals.com
View ArticleEpizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs
Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs Fierce Biotech
View ArticleThe Best- And Worst-Performing Biotech Stocks July 5 To July 12
The Best- And Worst-Performing Biotech Stocks July 5 To July 12 Forbes
View ArticleThe Best- And Worst-Performing Biotech Stocks July 19 To July 26
The Best- And Worst-Performing Biotech Stocks July 19 To July 26 Forbes
View ArticleEpizyme receives ophran drug designation for EPZ-5676
Epizyme receives ophran drug designation for EPZ-5676 Yahoo/Fly on the Wall
View ArticleEpizyme: The Promise Of Personalized Cancer Therapy
Epizyme: The Promise Of Personalized Cancer Therapy Seeking Alpha
View ArticleKeep an Eye on Pacific Biosciences, Epizyme, and Merrimack Today
Keep an Eye on Pacific Biosciences, Epizyme, and Merrimack Today Motley Fool
View ArticleValeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics Yahoo/Investors Business Daily
View ArticleThe Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10 Forbes
View ArticleCellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin Seeking Alpha
View ArticleBiotech Stocks Get Turbo Boost From Idenix Deal
Biotech Stocks Get Turbo Boost From Idenix Deal Seeking Alpha
View Article
